LYTIR

Insider · SEC Form 4 · Co-Chief Executive Officer

Joshua B. Cohen

Filed with the SEC as Cohen Joshua B; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: sold $4.0M of AMLX. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.0M in total.Sep: Insider sales $981KNov: Insider sales $3.0MDecJanFebMarAprMayJunJulAugSepOctNov$3.0M
Insider purchases above the line: $0Insider sales below: $4.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. AMLXSold: Amylyx Pharmaceuticals, Inc. Nov 9, 2026 100,000 shares filed Nov 12, 2026 2 transactions 10b5-1 plan filing $3.0M
  2. AMLXSold: Amylyx Pharmaceuticals, Inc. Sep 10, 2026 30,464 shares filed Sep 14, 2026 2 transactions filing $981K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. AMLXJOSHUA BARRY COHEN filed Nov 9, 2026 Amylyx Pharmaceuticals, Inc. Director 100,000 shares planned sale date 11/09/2026 filing $3.0M
  2. AMLXCohen Joshua B filed Sep 11, 2026 Amylyx Pharmaceuticals, Inc. Officer 30,464 shares planned sale date 09/10/2026 filing $981K

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • AMLX: grant or award (code A), 1 entry, Aug 18, 2026
Code A
A grant or award from the company, such as stock given as pay.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.